Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice - Archive ouverte HAL Access content directly
Conference Papers Year : 2019

Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

Domains

Life Sciences [q-bio]

Hélène CASTEL  : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-02294639

Submitted on : Monday, September 23, 2019-3:57:08 PM

Last modification on : Wednesday, March 2, 2022-3:48:02 PM

Not file

Dates and versions

hal-02294639 , version 1 (23-09-2019)

Identifiers

  • HAL Id : hal-02294639 , version 1

Cite

Hélène Castel, T Al Sagheer, Martine Dubois, Cynthia Campart, Laurence Desrues, et al.. Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. 2019 ASCO annual meeting, May 2019, Chicago, United States. ⟨hal-02294639⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

COMUE-NORMANDIE UNIROUEN DC2N
27 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More